Noribogaine Generalization to the Ibogaine Stimulus: Correlation with Noribogaine Concentration in Rat Brain
暂无分享,去创建一个
M. Shoaib | D. Mash | J. Pablo | I. Stolerman | C. Zubaran
[1] J. C. Winter,et al. Behavioral and Biochemical Evidence for a Nonessential 5-HT2A Component of the Ibogaine-Induced Discriminative Stimulus , 1998, Pharmacology Biochemistry and Behavior.
[2] J. C. Winter,et al. The Effects of Sigma, PCP, and Opiate Receptor Ligands in Rats Trained With Ibogaine as a Discriminative Stimulus , 1998, Pharmacology Biochemistry and Behavior.
[3] H. Jones,et al. Failure of Ibogaine to Produce Phencyclidine-Like Discriminative Stimulus Effects in Rats and Monkeys , 1998, Pharmacology Biochemistry and Behavior.
[4] Ying-Jun Cao,et al. Effects of noribogaine on the development of tolerance to antinociceptive action of morphine in mice , 1997, Brain Research.
[5] S. D. Glick,et al. Time-dependent interactions between iboga agents and cocaine. , 1997, European journal of pharmacology.
[6] J. C. Winter,et al. The effects of noribogaine and harmaline in rats trained with ibogaine as a discriminative stimulus. , 1997, Life sciences.
[7] Martin D. Schechte. Serotonergic mediation of fenfluramine discriminative stimuli in fawn-hooded rats. , 1997 .
[8] L. Farde,et al. The relevance of serotonergic mechanisms in the treatment of schizophrenia has not been confirmed , 1997, Journal of psychopharmacology.
[9] A. Scallet,et al. NOS and fos in Rat and Mouse Brain Regions , 1996, Annals of the New York Academy of Sciences.
[10] S. D. Glick,et al. 18-Methoxycoronaridine, a non-toxic iboga alkaloid congener: effects on morphine and cocaine self-administration and on mesolimbic dopamine release in rats , 1996, Brain Research.
[11] S. D. Glick,et al. Ibogaine-like effects of noribogaine in rats , 1996, Brain Research.
[12] A. Jeffcoat,et al. Determination of ibogaine in plasma by gas chromatography--chemical ionization mass spectrometry. , 1996, Journal of chromatography. A.
[13] S. D. Glick,et al. Tissue distribution of ibogaine after intraperitoneal and subcutaneous administration. , 1996, Life sciences.
[14] J. Witkin,et al. Discriminative stimulus effects of R-(+)-3-amino-1-hydroxypyrrolid-2-one, [(+)-HA-966], a partial agonist of the strychnine-insensitive modulatory site of the N-methyl-D-aspartate receptor. , 1995, The Journal of pharmacology and experimental therapeutics.
[15] P. Skolnick,et al. NMDA antagonist properties of the putative antiaddictive drug, ibogaine. , 1995, The Journal of pharmacology and experimental therapeutics.
[16] W. Hearn,et al. Identification and quantitation of ibogaine and an o-demethylated metabolite in brain and biological fluids using gas chromatography-mass spectrometry. , 1995, Journal of analytical toxicology.
[17] D. Mash,et al. Identification of a primary metabolite of ibogaine that targets serotonin transporters and elevates serotonin. , 1995, Life sciences.
[18] R. A. Davidoff,et al. Properties of ibogaine and its principal metabolite (12-hydroxyibogamine) at the MK-801 binding site of the NMDA receptor complex , 1995, Neuroscience Letters.
[19] Siming Li,et al. Expression and localization of inhibin α-subunit in rat retinal photoreceptor cells , 1995 .
[20] S. D. Glick,et al. Radioligand-binding study of noribogaine, a likely metabolite of ibogaine , 1995, Brain Research.
[21] S. G. Sheppard. A preliminary investigation of ibogaine: case reports and recommendations for further study. , 1994, Journal of substance abuse treatment.
[22] T. L. Gordon,et al. Comparison of the behavioral effects of ibogaine from three sources: mediation of discriminative activity. , 1993, European journal of pharmacology.
[23] S. Cappendijk,et al. Inhibitory effects of ibogaine on cocaine self-administration in rats. , 1993, European journal of pharmacology.
[24] J. C. Winter,et al. Stimulus effects of ibogaine in rats trained with yohimbine, DOM, or LSD , 1992, Pharmacology Biochemistry and Behavior.
[25] S. D. Glick,et al. Mechanisms of action of ibogaine and harmaline congeners based on radioligand binding studies , 1992, Brain Research.
[26] S. D. Glick,et al. Interactions between ibogaine, a potential anti-addictive agent, and morphine: an in vivo microdialysis study. , 1991, European journal of pharmacology.
[27] D. Sanger,et al. The discriminative stimulus effects of MK-801: Generalization to other N-methyl-D-aspartate receptor antagonists , 1989, Journal of psychopharmacology.
[28] G. Zetler,et al. Cerebral pharmacokinetics of tremor-producing harmala and iboga alkaloids. , 1972, Pharmacology.